34.06
-0.89 (-2.55%)
| Penutupan Terdahulu | 34.95 |
| Buka | 34.83 |
| Jumlah Dagangan | 191,266 |
| Purata Dagangan (3B) | 796,870 |
| Modal Pasaran | 1,942,486,144 |
| Harga / Pendapatan (P/E TTM) | 16.14 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.84 |
| Harga / Jualan (P/S) | 2.97 |
| Harga / Buku (P/B) | 3.34 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 20 Feb 2025 - 24 Feb 2025 |
| Margin Keuntungan | 17.98% |
| Margin Operasi (TTM) | 33.17% |
| EPS Cair (TTM) | 2.11 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 16.10% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 19.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 31.04% |
| Nisbah Semasa (MRQ) | 3.24 |
| Aliran Tunai Operasi (OCF TTM) | 220.92 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 168.65 M |
| Pulangan Atas Aset (ROA TTM) | 12.85% |
| Pulangan Atas Ekuiti (ROE TTM) | 22.75% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Harmony Biosciences Holdings, I | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.50 |
|
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 11.62% |
| % Dimiliki oleh Institusi | 93.13% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Valor Management Llc | 30 Sep 2024 | 11,218,033 |
| Venbio Partners Llc | 30 Sep 2024 | 614,594 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 75.00 (HC Wainwright & Co., 120.20%) | Beli |
| Median | 55.00 (61.48%) | |
| Rendah | 40.00 (Raymond James, 17.44%) | Beli |
| Purata | 56.00 (64.42%) | |
| Jumlah | 6 Beli | |
| Harga Purata @ Panggilan | 34.11 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 17 Dec 2024 | 75.00 (120.20%) | Beli | 33.63 |
| Cantor Fitzgerald | 30 Oct 2024 | 58.00 (70.29%) | Beli | 33.80 |
| Needham | 30 Oct 2024 | 52.00 (52.67%) | Beli | 33.80 |
| 29 Oct 2024 | 52.00 (52.67%) | Beli | 41.49 | |
| Oppenheimer | 30 Oct 2024 | 59.00 (73.22%) | Beli | 33.80 |
| Mizuho | 10 Oct 2024 | 52.00 (52.67%) | Beli | 34.81 |
| Raymond James | 10 Oct 2024 | 40.00 (17.44%) | Beli | 34.81 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |